Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CHROMA Call Transcript 2025

Apr 30, 2025

52029_rns_2025-04-30_af424b0e-0ddd-433a-9316-d15470ea91a1.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [141 x 48] intentionally omitted <==

==> picture [323 x 112] intentionally omitted <==

2025.1Q Earnings Conference Call

Paul Ying, CFO

30[th] April, 2025

1

Disclaimer

==> picture [141 x 48] intentionally omitted <==

This presentation contains some forward-looking statements that are subject to substantial risks and uncertainties. Typically, these statements contain words such as “anticipate”, “believe”, “could”, “estimate”, “expect”, “intend”, “plan”, “forecast”, “project”, “predict”, “potential”, “continue”, “may”, “should”, “will”, and “would” or similar words. You should consider these forward-looking statements carefully because such statements are only our expectations or projections about future events, and actual results may differ materially from those expressed or implied by such statements. The forward-looking statements in this presentation include, but are not limited to, growth rates for various markets estimated by third party sources, future products and technology development, widespread market acceptance of the hosted delivery model, future revenue growth and profitability. You should be cautioned that the forward-looking statements are no guarantee of our future performance. The forward-looking statements contained in this presentation are made only as of the date of this presentation and we undertake no obligation to update the forward-looking statements to reflect subsequent events or circumstances, except as required by law.

This presentation and the information contained herein are the property of Chroma Ate Inc.

==> picture [917 x 37] intentionally omitted <==

2

Agenda

==> picture [141 x 48] intentionally omitted <==

==> picture [720 x 456] intentionally omitted <==

----- Start of picture text -----


Financial Review

Operation Highlights

Q&A
----- End of picture text -----

3

==> picture [15 x 439] intentionally omitted <==

FINANCIAL REVIEW

==> picture [671 x 11] intentionally omitted <==

==> picture [917 x 37] intentionally omitted <==

4

==> picture [141 x 48] intentionally omitted <==

Year 2025.1Q Condensed Consolidated Income Statement

==> picture [834 x 26] intentionally omitted <==

----- Start of picture text -----

Condensed Consolidated P&L 2025.1Q % 2024.4Q % QoQ % 2024.1Q % YoY %
----- End of picture text -----

2025.1Q
%
2025.1Q
%
(In Million NTD, except for EPS in NTD)
Net Sales 6,865
100%
6,039
100%
14%
4,418
100%
55%
Consolidated Sales of Testing Equipment Business 6,456
94%
5,755
95%
12%
4,259
96%
52%
Consolidated Sales of MAS 349
5%
211
4%
65%
86
2%
306%
Others 60
1%
73
1%
(18%)
73
2%
(18%)
Cost of Goods Sold (2,717)
(40%)
(2,432)
(40%)
12%
(1,852)
(42%)
47%
Gross Profit 4,148
60%
3,607
60%
15%
2,566
58%
62%
Operating Expenses:
General & Administration
Research & Development
(1,378)
(20%)
(606)
(9%)
(1,364)
(23%)
1%
(1,181)
(27%)
17%
(684)
(11%)
(11%)
(485)
(11%)
25%
Operating Income 2,164
31%
1,559
26%
39%
900
20%
140%
Non-Operating Income (Expenses), net 433
6%
380
6%
14%
319
7%
36%
Income (Loss) Before Tax
Income Tax
2,597
37%
(441)
(6%)
1,939
32%
34%
1,219
27%
113%
(403)
(7%)
9%
(243)
(5%)
81%
Net Income 2,156
31%
1,536
25%
40%
976
22%
121%
Net Income (Losses) Attributable To:
Shareholders of the Parent
Noncontrolling Interests
2,123
31%
33
-
1,476
24%
44%
955
22%
122%
60
1%
(45%)
21
-
57%
$ 2,156
31%
$ 1,536
25%
40%
$ 976
22%
121%
EPS (Basic) $ 5.03 $ 3.49
44%
$ 2.27
122%
EPS (Diluted) $ 4.98 $ 3.45
44%
$ 2.25
121%

5

Balance Sheet Highlights & Financial Ratio

==> picture [141 x 48] intentionally omitted <==

Consolidated
(In Million NTD)
2025. March 2024. Dec + / - %
Balance Sheet Highlights
Cash & Short Term Investments 6,051 5,040 20%
Inventory 5,702 5,458 4%
Short Term Debt 101 1,417 - 93%
Long Term Debt 2,339 2,108 11%
Shareholders Equity 24,115 25,450 - 5%
Total Assets 38,724 37,308 4%
Inventory Turnover (Day) 185 209
AR Turnover (Day) 76 87
AP Turnover (Day) 105 118
Net Debt to Equity (%) Net Cash Net Cash
ROE (%) 34% 22%
ROA (%) 22% 15%
Cash Position 2025.1Q 2024.1Q YoY
EBITDA 2,810 1,420 98%
Cash Flow from Operation 1,956 1,213 61%
Free Cash Flow 1,968 804 145%

==> picture [9 x 9] intentionally omitted <==

All ROE + ROA has been annualized.

Free Cash Flow = Net Cash Provided by Operating Activities + (Net Cash used by Investing Activities)

6

==> picture [15 x 439] intentionally omitted <==

OPERATION

==> picture [671 x 11] intentionally omitted <==

HIGHLIGHT

==> picture [917 x 37] intentionally omitted <==

7

2025.1Q Product Mix and Consolidated Sales Breakdown

==> picture [141 x 48] intentionally omitted <==

(Unit: Million NTD) 2025.1Q
%
QoQ
YoY
2024
%
Test Instruments & Automatic Testing System (ATS) 2,205
42%
31%
32%
6,825
44%
Semiconductor / Photonics Test Solutions 2,602
50%
25%
118%
6,974
45%
Turnkey Solutions 150
3%
3%
(45%)
685
4%
Service & Others 282
5%
3%
11%
1,168
7%
Total of Parent Company Sales 5,239
100%
25%
54%
15,652
100%
+ Sales from Overseas Operations & Related
Subsidiaries
1,217
(22%)
41%
4,767
Chroma Consolidated Testing Equipment Business 6,456
94%
12%
52%
20,419
95%
MAS
Other Subsidiaries
349
5%
65%
306%
60
1%
(18%)
(18%)
872
4%
313
1%
Consolidated Sales 6,865
100%
14%
55%
21,604
97%

8

==> picture [141 x 48] intentionally omitted <==

==> picture [202 x 203] intentionally omitted <==

==> picture [585 x 195] intentionally omitted <==

Thank You

9 Copyright © 2023 Chroma ATE Inc. All rights reserved.